ArticleFrontiers in immunology2021

A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus.

Lei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.